Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Afrocentric InvestmentJSE:ACT 52 Debt-to-Equity is 0.39 as of Dec. 2025, which is 34% above its 10-year median of 0.29. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.07 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 558 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 51.08% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Afrocentric Investment's Debt-to-Equity or its related term are showing as below:
JSE:ACT'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.29 Max: 0.43
Current: 0.39
During the past 13 years, the highest Debt-to-Equity Ratio of Afrocentric Investment was 0.43. The lowest was 0.01. And the median was 0.29.
JSE:ACT's Debt-to-Equity is ranked better than 51.08% of 558
companies
in the Healthcare Providers & Services industry
Industry Median: 0.405
vs JSE:ACT: 0.39
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Afrocentric Investment Debt-to-Equity Related Terms
Afrocentric Investment Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Afrocentric Investment's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ACT vs HCA, THC, DVA: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afrocentric Investment (JSE:ACT) has a Debt-to-Equity of 0.39 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Afrocentric Investment and its competitors. This is 34% above median its historical median of 0.29. Over the past decade, Afrocentric Investment's Debt-to-Equity has ranged from 0.01 to 0.43. According to the industry distribution chart, Afrocentric Investment ranks #273 out of 558 companies in the Healthcare Providers & Services industry, placing it in the top 48.9%.
Is Afrocentric Investment's Debt-to-Equity too high?
Afrocentric Investment's current Debt-to-Equity of 0.39 is 34% above median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.43. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. Afrocentric Investment's value of 0.39 is 3.7% below this industry median. Based on the distribution chart, Afrocentric Investment ranks #273 out of 558 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #273 out of 558 companies for Debt-to-Equity. This puts Afrocentric Investment in the upper half of its industry. The industry median Debt-to-Equity is 0.41. Afrocentric Investment's value of 0.39 is 3.7% below this benchmark. Historically, Afrocentric Investment's own Debt-to-Equity has ranged from 0.01 to 0.43 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 0.41, Afrocentric Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 558 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current Debt-to-Equity of 0.39 is 3.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current Debt-to-Equity is 0.39, which is 34% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.07, compared to a current price of R0.80 — trading 61.4% below its estimated fair value. The current Debt-to-Equity is 0.39, which is 34% above median its 10-year median of 0.29 and 3.7% below the Healthcare Providers & Services industry median of 0.41. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Debt-to-Equity is 0.39 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.80 is trading 61.4% below its estimated GF Value™ of R2.07.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Debt-to-Equity: 0.39 (34% above median its 10-year median of 0.29)
GF Value™: R2.07 vs. price of R0.80 (61.4% below fair value)
Industry Position: 3.7% below the Healthcare Providers & Services median (#273 of 558)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
